+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A proteomic workflow for discovery of serum carrier protein-bound biomarker candidates of alcohol abuse using LC-MS/MS



A proteomic workflow for discovery of serum carrier protein-bound biomarker candidates of alcohol abuse using LC-MS/MS



Electrophoresis 30(12): 2207-2214



The diagnosis and care of patients with alcohol abuse and dependence is hampered by a lack of sensitive and specific screening and monitoring tests. Proteomics is a good approach to search for biomarkers of alcohol abuse. Serum carrier protein-bound proteins have attracted significant interest because they remain a relatively un-mined region of the proteome. In the present study, a proteomic workflow including LC-MS/MS with enrichment of serum carrier protein-bound biomarkers technique was applied to profile the changes in quality and quantity of serum carrier protein-bound proteins for the discovery of novel biomarker candidates of alcohol abuse. In total, 311 proteins identified with high confidence were discovered to be bound to serum carrier proteins. Complement isoforms, Ig fragments, and apolipoprotein family proteins are the main serum carrier-bound proteins. Protein quantification analysis with and without concern as to gender revealed that gender is a critical consideration for biomarker development in alcohol abuse. Identified proteins not previously associated with alcohol abuse include gelsolin, selenoprotein P, serotransferrin, tetranectin, hemopexin, histidine-rich glycoprotein, plasma kallikrein, and vitronectin. Altered abundance of these proteins suggests that they may be potential novel biomarkers for alcohol abuse.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051223384

Download citation: RISBibTeXText

PMID: 19544491

DOI: 10.1002/elps.200800775


Related references

A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples. Clinical Chemistry 53(6): 1067-1074, 2007

Fast quantitative urinary proteomic profiling workflow for biomarker discovery in kidney cancer. Clinical Proteomics 15: 42-42, 2019

Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury. Molecular and Cellular Proteomics 14(9): 2375-2393, 2016

A Highly Automated Shotgun Proteomic Workflow: Clinical Scale and Robustness for Biomarker Discovery in Blood. Methods in Molecular Biology 1619: 433-449, 2018

Comprehensive and Scalable Highly Automated MS-Based Proteomic Workflow for Clinical Biomarker Discovery in Human Plasma. Journal of Proteome Research 2014, 2014

Discovery of urinary biomarker candidates for prostate cancer based on proteomic analyses. European Urology Suppl.s 13(1): e202-e202a, 2014

Prostate cancer serum biomarker discovery through proteomic analysis of alpha-2 macroglobulin protein complexes. Proteomics. Clinical Applications 2(9): 1223, 2008

Serum Glycoprotein Biomarker Discovery and Qualification Pipeline Reveals Novel Diagnostic Biomarker Candidates for Esophageal Adenocarcinoma. Molecular and Cellular Proteomics 14(11): 3023-3039, 2016

Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum. Journal of Proteome Research 10(1): 133-142, 2011

Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia. Journal of Proteome Research 7(6): 2332-2341, 2008

Validation of a novel shotgun proteomic workflow for the discovery of protein-protein interactions: focus on ZNF521. Journal of Proteome Research 14(4): 1888-1899, 2016

Proteomic methods for biomarker discovery in a rat model of alcohol steatosis. Methods in Molecular Biology 909: 259-277, 2012

High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures. Clinical Chemistry 51(10): 1946-1954, 2005

Proteomic approaches for serum biomarker discovery in cancer. Anticancer Research 27(3a): 1247-1255, 2007

Discovery of colorectal cancer biomarker candidates by membrane proteomic analysis and subsequent verification using selected reaction monitoring (SRM) and tissue microarray (TMA) analysis. Molecular and Cellular Proteomics 13(6): 1471-1484, 2015